Skip to main content
. 2021 Oct 26;13(21):5359. doi: 10.3390/cancers13215359

Table 4.

Univariate Cox regression analysis for the prediction of sex-specific postoperative overall survival.

Parameter Sex Univariate Cox Regression
p-Value Hazard Ratio (95% CI)
Age m 0.288 1.023 (0.981–1.068)
f 0.087 1.035 (0.995–1.078)
Height cm m 0.673 0.989 (0.937–1.043)
f 0.172 1.035 (0.985–1.088)
Weight kg m 0.094 0.977 (0.951–1.004)
f 0.384 1.013 (0.984–1.043)
BMI m 0.132 0.932 (0.851–1.021)
f 0.683 1.019 (0.930–1.116)
Sodium m 0.059 0.887 (0.783–1.005)
f 0.381 1.042 (0.950–1.144)
Potassium m 0.156 0.477 (0.172–1.326)
f 0.360 0.716 (0.349–1.466)
Creatinine m 0.420 1.877 (0.407–8.660)
f 0.324 0.720 (0.375–1.384)
GFR m 0.174 0.986 (0.965–1.006)
f 0.993 1.000 (0.987–1.013)
Urea m 0.118 1.037 (0.991–1.085)
f 0.816 0.997 (0.971–1.023)
Uric acid f 0.538 0.772 (0.338–1.761)
f 0.856 1.004 (0.963–1.047)
Bilirubin m 0.002 3.925 (1.676–9.190)
f 0.975 0.997 (0.810–1.227)
AST m 0.879 1.001 (0.993–1.008)
f 0.028 1.000 (1.000–1.001)
γGT m 0.135 1.003 (0.999–1.006)
f 0.604 1.000 (0.999–1.001)
AP m 0.003 1.011 (1.004–1.018)
f 0.721 1.000 (0.999–1.002)
Albumin m 0.133 0.153 (0.013–1.774)
f 0.836 0.916 (0.399–2.102)
TSH m 0.618 0.904 (0.608–1.345)
f 0.899 0.984 (0.770–1.257)
CEA m 0.262 1.048 (0.965–1.139)
f 0.235 1.011 (0.993–1.029)
AFP m 0.342 1.021 (0.978–1.065)
f 0.131 1.027 (0.992–1.064)
CA19-9 m 0.061 1.000 (1.000–1.000)
f 0.958 1.000 (1.000–1.000)
INR m 0.699 2.320 (0.033–165.530)
f 0.347 3.153 (0.287–34.599)
aPTT m 0.341 0.931 (0.802–1.079)
f 0.115 1.035 (0.992–1.081)
UICC stage m 0.040
f 0.004
L3SMI (cm2/m2) m 0.018 0.940 (0.893–0.990)
f 0.283 0.967 (0.921–1.015)
L3PMI (cm2/m2) m 0.001 0.393 (0.224–0.688)
f 0.069 0.468 (0.206–1.060)

BMI: Body-Mass Index, GFR: glomerular filtration rate, AST: aspartate-aminotransferase, γGT: γ-glutamyltransferase; AP: Alkaline phosphatase; TSH: Thyroid-stimulating hormone, CEA: Carcinoembryonic antigen, AFP: α-fetoprotein, CA19-9: Carbohydrate antigen 19-9, INR: International normalized ratio, aPTT: activated partial thromboplastin time, m: male, f: female.